74 related articles for article (PubMed ID: 29629945)
1. Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez Pereña A; Marcos Gonzalez S; Teran-Villagra N; Azueta A; Batlle A; Gonzalez de Villambrosia S; Revert Arce J; Montes-Moreno S
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):e68-e71. PubMed ID: 29629945
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
Kersten MJ; Kraan W; Doorduijn J; Bromberg J; Lam K; Kluin PM; van der Holt BJ; Spaargaren M; Pals ST
Blood Cancer J; 2014 Dec; 4(12):e266. PubMed ID: 25501023
[No Abstract] [Full Text] [Related]
3. Pathology and new insights in central nervous system lymphomas.
Lebrun L; Allard-Demoustiez S; Salmon I
Curr Opin Oncol; 2023 Sep; 35(5):347-356. PubMed ID: 37439536
[TBL] [Abstract][Full Text] [Related]
4. Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract][Full Text] [Related]
5. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14.
Choi J; Phelan JD; Wright GW; Häupl B; Huang DW; Shaffer AL; Young RM; Wang Z; Zhao H; Yu X; Oellerich T; Staudt LM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6092-6102. PubMed ID: 32127472
[TBL] [Abstract][Full Text] [Related]
6. Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.
Lenz G; Hawkes E; Verhoef G; Haioun C; Thye Lim S; Seog Heo D; Ardeshna K; Chong G; Haaber J; Shi W; Gorbatchevsky I; Lippert S; Hiemeyer F; Piraino P; Beckmann G; Peña C; Buvaylo V; Childs BH; Salles G
Leukemia; 2020 Aug; 34(8):2184-2197. PubMed ID: 32060403
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
8. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract][Full Text] [Related]
9. Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ.
Koh HH; Yoon SE; Kim SJ; Kim WS; Cho J
Cancer Med; 2023 Oct; 12(19):19732-19743. PubMed ID: 37706649
[TBL] [Abstract][Full Text] [Related]
10. Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.
Todorovic Balint M; Jelicic J; Mihaljevic B; Kostic J; Stanic B; Balint B; Pejanovic N; Lucic B; Tosic N; Marjanovic I; Stojiljkovic M; Karan-Djurasevic T; Perisic O; Rakocevic G; Popovic M; Raicevic S; Bila J; Antic D; Andjelic B; Pavlovic S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164089
[TBL] [Abstract][Full Text] [Related]
11. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8.
Mandato E; Yan Q; Ouyang J; Paczkowska J; Qin Y; Hao Y; Bojarczuk K; Hansen J; Chapuy B; Rodig SJ; Khan SJ; Redd RA; Shipp MA
Blood; 2023 Oct; 142(14):1219-1232. PubMed ID: 37467575
[TBL] [Abstract][Full Text] [Related]
12. An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma.
Flümann R; Hansen J; Meinel J; Pfeiffer P; Goldfarb Wittkopf H; Lütz A; Wirtz J; Möllmann M; Zhou T; Tabatabai A; Lohmann T; Jauch M; Beleggia F; Pelzer B; Ullrich F; Höfmann S; Arora A; Persigehl T; Büttner R; von Tresckow B; Klein S; Jachimowicz RD; Reinhardt HC; Knittel G
Blood Adv; 2024 Mar; 8(5):1063-1074. PubMed ID: 38060829
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Mutations in Refractory/Relapsed Diffuse Large B-Cell Lymphoma by Targeted Gene Sequencing.
Sharma A; Das A; Bal A; Srinivasan R; Malhotra P; Prakash G; Kumar R
Cytogenet Genome Res; 2023; 163(5-6):279-289. PubMed ID: 38071955
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract][Full Text] [Related]
15. Loss of TNFAIP3 enhances MYD88
Wenzl K; Manske MK; Sarangi V; Asmann YW; Greipp PT; Schoon HR; Braggio E; Maurer MJ; Feldman AL; Witzig TE; Slager SL; Ansell SM; Cerhan JR; Novak AJ
Blood Cancer J; 2018 Oct; 8(10):97. PubMed ID: 30301877
[TBL] [Abstract][Full Text] [Related]
16. Primary Large B-cell Lymphomas of Immune-Privileged Sites.
Roschewski M; Phelan JD; Jaffe ES
Blood; 2024 Apr; ():. PubMed ID: 38635786
[TBL] [Abstract][Full Text] [Related]
17. Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma.
Benitez-Cantos MS; Cano C; Cuadros M; Medina PP
Mol Cancer; 2024 Feb; 23(1):42. PubMed ID: 38402205
[TBL] [Abstract][Full Text] [Related]
18. Aggressive lymphomas.
Lenz G; Staudt LM
N Engl J Med; 2010 Apr; 362(15):1417-29. PubMed ID: 20393178
[TBL] [Abstract][Full Text] [Related]
19. Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.
Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Schlick K; Zaborsky N; Steiner M; Greil R; Egle A; Melchardt T
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33561953
[TBL] [Abstract][Full Text] [Related]
20. Fibrin-associated large B-cell lymphoma shows frequent mutations related to immune surveillance and PTEN.
Boyer DF; Perry A; Wey E; Hsueh J; Li A; Jackson R; Soma L; Zhang W; Song JY
Blood; 2023 Sep; 142(11):1022-1025. PubMed ID: 37433264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
